Brief: Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'grady As Chief Executive Officer To Lead Strategic Growth
28/07/2026 12:47
BRIEF-Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'grady As Chief Executive Officer To Lead Strategic Growth July 28 (Reuters) - Nasus Pharma Ltd NSRX.A:
NASUS PHARMA APPOINTS PHARMACEUTICAL INDUSTRY VETERAN BRENDAN P. O'GRADY AS CHIEF EXECUTIVE OFFICER TO LEAD STRATEGIC GROWTH
NASUS PHARMA - BRENDAN P. O'GRADY SUCCEEDS DAN TELEMAN AS CEO EFFECTIVE JULY 27, 2026
Source text: ID:nGNXb4T2bd
Further company coverage: NSRX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nasus Pharma
See all newsBrief: Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'grady As Chief Executive Officer To Lead Strategic Growth
Brief: Nasus Pharma Announces Positive Top Line Data From Phase 2 Clinical Study Of Ns002 Achieves Significantly Superior And Faster Epinephrine Delivery Compared To Epipen® With Accelerated Speed To Therapeutic Threshold
Brief: Nasus Pharma Announces Closing Of $15.0 Million Private Placement
Brief: Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin As Executive Vice President And Chief Financial Officer
Brief: Nasus Pharma Announces Initiation Of Phase 2 Clinical Study Of Ns002 With First Participant Dosed